A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of R-Verapamil in the Prophylaxis of Episodic Cluster Headache
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Apr 2017
At a glance
- Drugs R-verapamil (Primary)
- Indications Cluster headache
- Focus Therapeutic Use
- Sponsors Center Laboratories
- 24 Apr 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 24 Apr 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 31 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.